Acrivon Therapeutics

Acrivon Therapeutics

MA - Watertown
Biotechnology

Focus: Checkpoint Inhibitor

Acrivon Therapeutics is a life sciences company focused on Checkpoint Inhibitor.

Oncology
Open Jobs
3

Pipeline & Clinical Trials

Clinical Trials (1)
NCT06667141Phase 1 Study of ACR-2316 in Specific Advanced Solid Tumors
Phase 1
Clinical Trials (1)
NCT06597565A Phase II Study of ACR-368 and Low Dose Gemcitabine in R/M HNSCC
Phase 2
Clinical Trials (1)
NCT05548296A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
Phase 2

Open Jobs (3)

Interview Prep Quick Facts
Portfolio: 3 clinical trials
Open Roles: 3 active jobs

Hiring Trend

Stable
3
Open Roles
+0
Added
-0
Filled/Removed

Based on last 4 crawl cycles